Lataa...
Local pulsatile PTH delivery regenerates bone defect via enhanced bone remodeling in a cell-free scaffold
Parathyroid hormone (PTH) is currently the only FDA-approved anabolic drug to treat osteoporosis, and is systemically administered through daily injections. A new local pulsatile PTH delivery device was developed from biodegradable polymers to expand PTH’s application from osteoporosis treatment to...
Tallennettuna:
| Julkaisussa: | Biomaterials |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5125900/ https://ncbi.nlm.nih.gov/pubmed/27835763 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biomaterials.2016.10.049 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|